AstraZeneca overhauls management of its scandal-hit China division
- Posted on January 17, 2025
- By Financial Times
- 3 Views
AstraZeneca overhauls management of its scandal-hit China division
Arrest of FTSE 100 pharma group’s country president last year is expected to hit sales
